Quipt Q3 revenue $58.3M, down 4.1% YoY; net loss ($3.0M); acquires Ballad Health DME

Quipt Home Medical Corp.

2025-Q3 EPS reported -$0.17 revenue$177,046,000

Revenue $58.3M, down 4.1% YoY; net loss ($0.07) diluted EPS vs ($0.04) prior year.
Adjusted EBITDA $13.7M (23.5% of revenue), down 3.6% YoY; nine-month cash from ops $27.9M.
Quarter-over-quarter organic growth of 1.6% in revenue, 3.4% patient base growth.
Post-quarter acquired Ballad Health DME provider ($6.6M revenue) with PPA for referrals from 20 hospitals.
Net Debt/Adj. EBITDA leverage 1.5x; $35.3M total credit availability.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.